Share
Journal Information
Most Often Read
1676
Document of recommendations of the SEA 2018. Lifestyle in cardiovascular preventionFrancisco Pérez-Jiménez, Vicente Pascual, José Félix Meco, Pablo Pérez Martínez, Javier Delgado Lista, Monica Domenech, Ramon Estruch, Ana León-Acuña, José López-Miranda, Andrea Sánchez-Ramos, Cristina Soler i Ferrer, Cristina Soler-Rivas, Rosa Maria Solá Alberich, Pedro Valdivielso, Emilio Ros
Clin Investig Arterioscler. 2018;30:280-310
1676
Open access
1585
Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Society of Arteriosclerosis (SEA), 2019Juan Francisco Ascaso, Fernando Civeira, Carlos Guijarro, José López Miranda, Luis Masana, José María Mostaza, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso
Clin Investig Arterioscler. 2019;31:128-39
1585
Open access
367
Dyslipemias and pregnancy, an updateMarta Mauri, Pilar Calmarza, Daiana Ibarretxe
Clin Investig Arterioscler. 2021;33:41-52
367
Open access
273
Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®)Xavier Pintó, Luis Masana, Fernando Civeira, José Real, Daiana Ibarretxe, Beatriz Candas, José Puzo, José Luis Díaz, Núria Amigó, Margarita Esteban, Pedro Valdivielso
Clin Investig Arterioscler. 2020;32:219-29
273
Open access
197
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU)Lluís Masana, José López Miranda, Fernando Civeira, Leonardo Reinares, Carlos Guijarro, Núria Plana, Rafael Cuenca, Demetrio Sánchez, José Luis Hernández, Raimundo Andrés, Agustín Blanco, Santiago Villamayor
Clin Investig Arterioscler. 2020;32:183-92
197
Open access
71
Chronic kidney disease and dyslipidaemiaV. Pascual, A. Serrano, J. Pedro-Botet, J. Ascaso, V. Barrios, J. Millán, X. Pintó, A. Cases
Clin Investig Arterioscler. 2017;29:22-35
71
54
Lipid control in patients with coronary artery disease in a healthcare area in Cáceres (Spain): LIPICERES studyJosé J. Gómez-Barrado, Carolina Ortiz, Marta Gómez-Turégano, Paula Gómez-Turégano, Francisco J. Garcipérez-de-Vargas, Pablo Sánchez-Calderón
Clin Investig Arterioscler. 2017;29:13-9
54
52
Is regression of atherosclerotic plaque possible?José A. Páramo, Fernando Civeira
Clin Investig Arterioscler. 2017;29:46-50
52
51
Statin associated myopathy in clinical practice. Results of DAMA studyJesús Millán, Juan Pedro-Botet, Elisenda Climent, Joaquín Millán, Joan Rius
Clin Investig Arterioscler. 2017;29:7-12
51
49
A glow in the secondary prevention of cardiovascular diseaseJ. Pedro-Botet, E. Climent
Clin Investig Arterioscler. 2017;29:20-1
49
48
Potential protective role of nitric oxide and Hsp70 linked to functional foods in the atherosclerosisAlejandra B. Camargo, Walter Manucha
Clin Investig Arterioscler. 2017;29:36-45
48
38
Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary eventEfrén Martínez-Quintana, Fayna Rodríguez-González, José María Medina-Gil, Paloma Garay-Sánchez, Antonio Tugores
Clin Investig Arterioscler. 2017;29:1-6
38
34
Vascular lesions in patient with Takayasu arteritis and massive elevated lipoprotein (a) levels. Residual involvement or premature aterosclerosis?José Carlos Alarcón García, Santiago Rodríguez Suárez, Ovidio Muñiz Grijalvo, Salvador García Morillo
Clin Investig Arterioscler. 2017;29:98-102
34
29
SEA/SEMERGEN 2019 consensus document 2019. Dietary recommendations in the prevention of cardiovascular diseaseVicente Pascual, Pablo Perez Martinez, José Manuel Fernández, Rosa Solá, Vicente Pallarés, Anny Romero Secín, Francisco Pérez Jiménez, Emilio Ros
Clin Investig Arterioscler. 2019;31:186-201
29
27
Related cardiometabolic factors and prevalence of low HDL-cholesterol levels and atherogenic dyslipidemia. SIMETAP-AD studyAntonio Ruiz-García, Ezequiel Arranz-Martínez, María E. García-Fernández, Roberto Cabrera-Vélez, Rosa A. García-Pliego, Luis E. Morales-Cobos, Blanca Sanz-Pozo, Esther Gómez-Díaz, Enrique Rodríguez-de-Mingo, María R. Rico-Pérez, Alfonso Migueláñez-Valero, María P. Calderín-Morales, Eloína Sandín-de-Vega, María P. Hombrados-Gonzalo, Sonia Luna-Ramírez, María C. Sánchez-Ramos, Cristina Mora-Casado, María S. Moreno-Muñoz, Paloma González-Escobar, Lourdes Ruiz-Díaz, Nuria Caballero-Ramírez, María M. Zamora-Gómez, Nerea Iturmendi-Martínez, María S. Holgado-Catalán, Rebeca Álvarez-Benedicto, Pedro L. Sanchidriá-Fernández, Elena Benito-Alonso, Teresa Fernández-Vicente, Rosa M. Hernández-López, Norma A. Doria-Carlin, Manuel J. Frías-Vargas
Clin Investig Arterioscler. 2021;33:19-29
27
27
Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of ArteriosclerosisJuan F. Ascaso, Jesús Millán, Antonio Hernández-Mijares, Mariano Blasco, Ángel Brea, Ángel Díaz, Teresa Mantilla, Juan Pedro-Botet, Xavier Pintó
Clin Investig Arterioscler. 2017;29:86-91
27
22
Differential leucocyte RNA expression in the coronary arteries compared to systemic circulation discriminates between patients with and those without coronary artery diseaseJosep Ribalta, Arash Alipour, Fátima Sánchez-Cabo, Joan-Carles Vallvé, Tjin Njo, Rebeca Álvarez, Hans Janssen, Anho Liem, Ana Dopazo, Manuel Castro-Cabezas
Clin Investig Arterioscler. 2017;29:60-6
22
20
Mitochondrial dysfunction associated with nitric oxide pathways in glutamate neurotoxicityWalter Manucha
Clin Investig Arterioscler. 2017;29:92-7
20
19
Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosisIolanda Lazaro, Ainhoa Oguiza, Carlota Recio, Laura Lopez-Sanz, Susana Bernal, Jesus Egido, Carmen Gomez-Guerrero
Clin Investig Arterioscler. 2017;29:51-9
19
15
Treatment of a high cardiovascular risk patient with McArdle's disease with PCSK9 inhibitorsVictoria Marco-Benedí, Estíbaliz Jarauta, Sofía Pérez-Calahorra, Ana M. Bea, Fernando Civeira
Clin Investig Arterioscler. 2019;31:89-92
15